All stocks / BICX
BioCorRx Inc. BICX
BioCorRx (BICX): shares outstanding up 25% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- BIOCORRX INC
- Market tier
- OTC Pink Current
- Trading status
- Active
- Last trade
- Nov 16
- Website
- www.biocorrx.com
News headlines
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $797,244
- Net loss
- ($3,440,146)
It spends more than it earns
Under strainCustomers paid it $797,244 in the year. It lost $3.4 million. For every $1 that came in, about $5.32 went out.
- Cash and cash equivalents
- $139,360
- Net cash used in operating activities
- ($2,298,291)
The cash could run out soon
Under strainIt had $139,360 in the bank and used about $191,524 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.
- Total assets
- $2,147,212
- Total liabilities
- $13,674,200
It owes more than it owns
Under strainEverything the company owns adds up to $2.1 million. Its debts and unpaid bills add up to $13.7 million. That is about $6.37 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 24,489,311 (2025-12-31) to 30,643,140 (2026-11-16), up 25%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 30,643,140 shares as of 2026-11-16: 30,643,140 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about BICX
Does BICX file reports with the SEC?
Yes. BioCorRx files with the SEC under company number 0001443863. The most recent filing we hold is a 10-Q dated 2026-11-16.
Source recordHow many BICX shares are outstanding?
30,643,140 shares as of 2026-11-16, as reported to the SEC. That is up 25% from 24,489,311 on 2025-12-31.
Source recordHas BICX filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Is BioCorRx making money?
Customers paid it $797,244 in the year. It lost $3.4 million. For every $1 that came in, about $5.32 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record